Table 4 Multivariate analysis of prognostic factors impacting OSPT and OS.

From: Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants

Variables

OSPT

OS

HR (95%CI)

P-value

HR (95%CI)

P-value

Age ≥ 40y

  

2.17 (1.05–4.46)

0.035

RIC Conditioning

  

1.08 (0.36–3.21)

0.893

PBSCs

0.76 (0.46–1.25)

0.282

0.70 (0.42–1.15)

0.154

MSDT

1.32 (0.73–2.40)

0.360

1.58 (0.83–3.03)

0.167

ATG

0.42 (0.16−1.09)

0.075

0.37 (0.13–1.07)

0.067

EBV

0.22 (0.05–0.95)

0.042

0.19 (0.44–0.85)

0.029

  1. OSPT: overall survival post transplant; RIC: reduced intensive conditioning; PBSCs: peripheral blood stem cells; MSDT: matched sibling donor transplant; ATG: Rabbitantithymocyte globulin.
Back to article page